CN1051471C - Drug composition for curing osteoporosis - Google Patents

Drug composition for curing osteoporosis Download PDF

Info

Publication number
CN1051471C
CN1051471C CN97116955A CN97116955A CN1051471C CN 1051471 C CN1051471 C CN 1051471C CN 97116955 A CN97116955 A CN 97116955A CN 97116955 A CN97116955 A CN 97116955A CN 1051471 C CN1051471 C CN 1051471C
Authority
CN
China
Prior art keywords
parts
radix
gram
cordyceps
osteoporosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97116955A
Other languages
Chinese (zh)
Other versions
CN1179978A (en
Inventor
苏顺兴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97116955A priority Critical patent/CN1051471C/en
Publication of CN1179978A publication Critical patent/CN1179978A/en
Application granted granted Critical
Publication of CN1051471C publication Critical patent/CN1051471C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a medicine composition for curing osteoporosis. The medicine composition comprises the components of American ginseng, cordyceps, cooked rehmannia root, tortoise plastron, Chinese angelica root, red peony root, salvia root, Asiatic elder twig, pyrite, crab, oyster shell, rhubarb, prepared nux vomica, peach kernel and carthamus flower. The medicine composition can also be made into a conventional medicine preparation.

Description

A kind of pharmaceutical composition for the treatment of osteoporosis
The present invention is a kind of pharmaceutical composition for the treatment of osteoporosis, and the traditional Chinese herbal medicine that consists of China of said composition has favorable effects to the treatment and the prevention of osteoporosis, and the present invention also provides the medicament that is prepared from said composition.Belong to the field of Chinese medicines.
Along with the raising of modern life level, the population life-span increases gradually, and aging population are more and more, and the degeneration physiological decease-primary osteoporosis that brings has thus become one of important diseases of the elder's health.Osteoporosis is a kind of senile disease, commonly encountered diseases, the present domestic specific Chinese medicine preparation that still do not have.The feature of osteoporosis is that the bone amount is low, and the osseous tissue micro structure is degenerated and caused bone fragility to increase, and very easily causes compression fracture of lumbar vertebra, fracture of femoral neck and wrist portion, fracture of radius.These fracture, especially lumbar vertebra fracture often take place under the obvious external force effect not having, and usually show the unexpected back severe pain beginning to be found.Along with the growth in population life-span, the increasing of old number, the harm of this disease is just more and more serious.Therefore, seeking the Chinese medicine of a kind of effective prevention and treatment osteoporosis, is one of important topic of current medical circle.
The present invention seeks to develop a kind of pharmaceutical composition for the treatment of osteoporosis.
According to the theory of the traditional Chinese medical science " kidney governing bones ", it is that disease is basic that patients with osteoporosis is suffered from a deficiency of the kidney.The treatment of disease must aim at its pathogenesis, and suffer from a deficiency of the kidney and the branch of deficiency of the kidney yin, deficiency of the kidney yin is arranged.The utilization differential diagnosis in tcm execute the principle of controlling, according to the whole nation about deficiency of the kidney yin, insufficiency of kidney-YANG diagnostic criteria, to primary disease deficiency of the kidney yin person, tonifying kidney-yin, benefiting QI and nourishing blood, bone strengthening Shujin, promoting blood circulation to disperse blood clots and relieves pain.The inventor by a large amount of case summaries, has developed the medicine of the inclined to one side deficiency of the kidney yin of treatment osteoporosis in clinical practice.
Pharmaceutical composition of the present invention its composition by weight is:
Radix Panacis Quinquefolii 20-80 part
Cordyceps 10-40 part
Radix Rehmanniae Preparata 20-80 part
Carapax et Plastrum Testudinis 30-80 part
Radix Angelicae Sinensis 30-80 part
Radix Paeoniae Rubra 30-80 part
Radix Salviae Miltiorrhizae 30-80 part
Ramulus Sambuci Williamsii 80-120 part
Pyritum 80-120 part
Eriocheir sinensis 80-120 part
Concha Ostreae 80-120 part
Radix Et Rhizoma Rhei 30-80 part
Semen Strychni (processed) 30-80 part
Semen Persicae 30-80 part
Flos Carthami 10-40 part
Its preferred weight proportioning of pharmaceutical composition of the present invention is:
50 parts of Radix Panacis Quinquefoliis
25 parts of Cordyceps
50 parts in Radix Rehmanniae Preparata
50 parts of Carapax et Plastrum Testudiniss
50 parts of Radix Angelicae Sinensis
50 parts of Radix Paeoniae Rubra
50 parts of Radix Salviae Miltiorrhizaes
100 parts of Ramulus Sambuci Williamsii
100 parts of Pyritums
100 parts of Eriocheir sinensiss
100 parts of Concha Ostreaes
50 parts of Radix Et Rhizoma Rhei
50 parts of Semen Strychni (processed)
50 parts in Semen Persicae
15 parts on Flos Carthami
Pharmaceutical composition of the present invention can be prepared into any pharmaceutical dosage form that is suitable for using clinically according to the preparation process of routine.As, pill, tablet, capsule, random notes, syrup, oral liquid, suspensoid, granule etc.
In the above-mentioned pharmaceutical dosage form process of preparation cost invention, can add conventional drug excipient, for example, disintegrating agent, binding agent, flavoring agent, antiseptic, filler, solubilizing agent, cosolvent, lubricant, pigment etc.
The preparation method of bolus of drug of the present invention (commodity are called brave bone pellet) is:
With Radix Panacis Quinquefolii, Cordyceps, Eriocheir sinensis accelerated freeze-drying, be the end, keep biological activity.Pyritum, Concha Ostreae, Carapax et Plastrum Testudinis, Radix Et Rhizoma Rhei, Semen Strychni (processed) grind to the powder, and remaining all medicines are made clear paste by official preparation general rule regulation, mix with above-mentioned medicated powder then, and making pellets by mixing medical powder with honey, every ball weigh 6 grams.
The effect of medicine of the present invention is: tonifying kidney-yin, benefiting QI and nourishing blood, bone strengthening Shujin, blood circulation promoting and blood stasis dispelling.
Cure mainly: deficiency of the kidney yin type osteoporosis.
Clinical practice: osteoporosis, aching pain in waist and back, two knees soreness, fracture pain be double sees dizziness and blurred vision, hectic fever night sweat, dry mouth and throat, the few tongue of red tongue, thready and rapid pulse person, each clothes one ball, every day three times, sweetened vinegar is converted water for 25 milliliters and is taken in right amount after meal, and 30 days is a course of treatment.
From nineteen ninety-five to 1997 year, use Drug therapy osteoporosis patient 30 examples of the present invention.30 routine patient's bone X line plain films show: thoracic vertebra, hipbone all have bone density reduction in various degree.Wherein, 6 routine compression fracture of lumbar vertebra, 4 routine fracture of femoral neck, 1 routine fracture of radius, 1 routine hip fracture.30 routine patients all have lumbar and back pain medical history, knee joint and hip pain medical history in various degree.
Efficacy assessment standard to therapeutic outcome is:
Produce effects is pain complete obiteration after the medication, and movable function is significantly promoted;
Effectively be pain relief after the medication, movable function improves;
Invalid for pain after the medication does not alleviate, still need take other drug.
By above-mentioned therapeutic evaluation standard, therapeutic outcome such as following table:
Curative effect The example number The woman The man
The example number The example number
Produce effects 13 43 10 33.3 3 10
Effectively 15 50 10 33.3 5 16.8
Invalid 2 7 1 3.3 1 3.3
Medicine composite for curing osteoporosis total effective rate 93% of the present invention.
Embodiment 1
Radix Panacis Quinquefolii 50 gram Cordyceps 25 gram Radix Rehmanniaes Preparata 50 gram Carapax et Plastrum Testudiniss 50 grams
Radix Angelicae Sinensis 50 gram Radix Paeoniae Rubra 50 gram Radix Salviae Miltiorrhizaes 50 gram Ramulus Sambuci Williamsii 100 grams
Pyritum 100 gram Eriocheir sinensiss 100 gram Concha Ostreaes 100 gram Radix Et Rhizoma Rhei 50 grams
Semen Strychni (processed) 50 gram Semen Persicaes 50 gram Flos Carthamis 15 grams
Measure Radix Panacis Quinquefolii, Cordyceps, Eriocheir sinensis accelerated freeze-drying according to prescription, be the end, keep biological activity.Pyritum, Concha Ostreae, Carapax et Plastrum Testudinis, Radix Et Rhizoma Rhei, Semen Strychni (processed) are ground to the powder, and remaining all medicines are made clear paste by official preparation general rule regulation, mix with last medicated powder then, and making pellets by mixing medical powder with honey is made 100 balls, and every ball weighs 6 grams.
Embodiment 2
Radix Panacis Quinquefolii 60 gram Cordyceps 30 gram Radix Rehmanniaes Preparata 40 gram Carapax et Plastrum Testudiniss 40 grams
Radix Angelicae Sinensis 70 gram Radix Paeoniae Rubra 30 gram Radix Salviae Miltiorrhizaes 40 gram Ramulus Sambuci Williamsii 80 grams
Pyritum 90 gram Eriocheir sinensiss 90 gram Concha Ostreaes 90 gram Radix Et Rhizoma Rhei 40 grams
Semen Strychni (processed) 50 gram Semen Persicaes 60 gram Flos Carthamis 25 grams
Measure Radix Panacis Quinquefolii, Cordyceps, Eriocheir sinensis accelerated freeze-drying according to prescription, be the end, keep biological activity.Pyritum, Concha Ostreae, Carapax et Plastrum Testudinis, Radix Et Rhizoma Rhei, Semen Strychni (processed) grind to the powder, and remaining all medicines are made clear paste by official preparation general rule regulation, mix with last medicated powder then, and making pellets by mixing medical powder with honey, every ball weigh 6 grams.
Embodiment 3
Radix Panacis Quinquefolii 80 gram Cordyceps 10 gram Radix Rehmanniaes Preparata 80 gram Carapax et Plastrum Testudiniss 80 grams
Radix Angelicae Sinensis 40 gram Radix Paeoniae Rubra 50 gram Radix Salviae Miltiorrhizaes 80 gram Ramulus Sambuci Williamsii 120 grams
Pyritum 90 gram Eriocheir sinensiss 100 gram Concha Ostreaes 100 gram Radix Et Rhizoma Rhei 30 grams
Semen Strychni (processed) 40 gram Semen Persicaes 30 gram Flos Carthamis 20 grams
Measure Radix Panacis Quinquefolii, Cordyceps, Eriocheir sinensis accelerated freeze-drying according to prescription, be the end, keep biological activity.Pyritum, Concha Ostreae, Carapax et Plastrum Testudinis, Radix Et Rhizoma Rhei, Semen Strychni (processed) grind to the powder, and remaining all medicines are made clear paste by official preparation general rule regulation, mix with last medicated powder then, and making pellets by mixing medical powder with honey is made 100 balls, and every ball weighs 6 grams.

Claims (3)

1, a kind of pharmaceutical composition for the treatment of osteoporosis is characterized in that said composition adopts the raw material as active ingredient of following consumption to make:
Radix Panacis Quinquefolii 20-80 part
Cordyceps 10-40 part
Radix Rehmanniae Preparata 20-80 part
Carapax et Plastrum Testudinis 30-80 part
Radix Angelicae Sinensis 30-80 part
Radix Paeoniae Rubra 30-80 part
Radix Salviae Miltiorrhizae 30-80 part
Ramulus Sambuci Williamsii 80-120 part
Pyritum 80-120 part
Eriocheir sinensis 80-120 part
Concha Ostreae 80-120 part
Radix Et Rhizoma Rhei 30-80 part
Semen Strychni (processed) 30-80 part
Semen Persicae 30-80 part
Flos Carthami 10-40 part.
2, the pharmaceutical composition above-mentioned according to claim 1 is characterized in that the weight ratio of described each component is:
50 parts of Radix Panacis Quinquefoliis
25 parts of Cordyceps
50 parts in Radix Rehmanniae Preparata
50 parts of Carapax et Plastrum Testudiniss
50 parts of Radix Angelicae Sinensis
50 parts of Radix Paeoniae Rubra
50 parts of Radix Salviae Miltiorrhizaes
100 parts of Ramulus Sambuci Williamsii
100 parts of Pyritums
100 parts of Eriocheir sinensiss
100 parts of Concha Ostreaes
50 parts of Radix Et Rhizoma Rhei
50 parts of Semen Strychni (processed)
50 parts in Semen Persicae
15 parts on Flos Carthami.
3, compositions according to claim 1 and 2 is characterized in that also containing in the said composition excipient.
CN97116955A 1997-09-29 1997-09-29 Drug composition for curing osteoporosis Expired - Fee Related CN1051471C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97116955A CN1051471C (en) 1997-09-29 1997-09-29 Drug composition for curing osteoporosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97116955A CN1051471C (en) 1997-09-29 1997-09-29 Drug composition for curing osteoporosis

Publications (2)

Publication Number Publication Date
CN1179978A CN1179978A (en) 1998-04-29
CN1051471C true CN1051471C (en) 2000-04-19

Family

ID=5174230

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97116955A Expired - Fee Related CN1051471C (en) 1997-09-29 1997-09-29 Drug composition for curing osteoporosis

Country Status (1)

Country Link
CN (1) CN1051471C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311919B2 (en) * 2003-04-17 2007-12-25 Simpson Biotech Co., Ltd. Agents for treating osteoporosis and inhibiting osteoclast formation
CN103349123A (en) * 2013-07-22 2013-10-16 北京绿源求证科技发展有限责任公司 Food health preserving tea electuary for preventing osteoporosis

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100391497C (en) * 2004-02-11 2008-06-04 辽宁中医学院 Nanometer Chinese traditional medicine for treating osteoporosis
CN101138597B (en) * 2007-08-31 2010-06-23 澳门科技大学 Traditional Chinese medicine preparation for preventing and controlling osteoporosis and method of preparing the same
CN102614339A (en) * 2011-06-07 2012-08-01 李学朋 Preparation method of Chinese patent medicine used for treating osteoporosis
CN104367629A (en) * 2014-11-06 2015-02-25 成都果睿医药科技有限公司 Pharmaceutical composition for treating osteoporosis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
中医杂志1992,23(11) 1992. 1. 1 梁立等,补肾中药治疗骨质节疏松症临床观察 *
中医杂志1992,23(9) 1992. 1. 1 王林元,新伤膏治疗髌骨软骨软化症76例报告 *
实用儿科临床杂志1990,5(4) 1990. 1. 1 尹钟洙,龙牡壮骨冲剂药理学研究 *
实用儿科临床杂志1990,5(4) 1990. 1. 1 尹钟洙,龙牡壮骨冲剂药理学研究;中医杂志1992,23(11) 1992. 1. 1 梁立等,补肾中药治疗骨质节疏松症临床观察;中医杂志1992,23(9) 1992. 1. 1 王林元,新伤膏治疗髌骨软骨软化症76例报告 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311919B2 (en) * 2003-04-17 2007-12-25 Simpson Biotech Co., Ltd. Agents for treating osteoporosis and inhibiting osteoclast formation
US7387781B2 (en) 2003-04-17 2008-06-17 Simpson Biotech Co., Ltd. Agents for treating osteoporosis and inhibiting osteoclast formation
CN103349123A (en) * 2013-07-22 2013-10-16 北京绿源求证科技发展有限责任公司 Food health preserving tea electuary for preventing osteoporosis

Also Published As

Publication number Publication date
CN1179978A (en) 1998-04-29

Similar Documents

Publication Publication Date Title
CN1061854C (en) Medicinal preparation for treatment and prevention of gynopathy
CN1857541A (en) Plaster for treating rheumatism and osteoarthrosis
CN101108226A (en) Medicament treating rheumatism, rheumatoid, woman's wind, osteoproliferation and slipped disc illness
CN1814208A (en) Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN101703662B (en) Oral Chinese medicament for treating hyperosteogeny
CN1051471C (en) Drug composition for curing osteoporosis
CN1966067A (en) Medicament for treating aplastic anemia
CN1502349A (en) Traditional Chinese medicine composition (Bushenzhuangyao Decoction) for reinforcing kidney and strengtening lumbar
CN1324650A (en) Effective medicine for treating cervical vertebra disease as one kind of intractable disease
CN1059115C (en) Drug composition for curing osteoporosis
CN1136899C (en) Chinese medicine for treating mastoplasia
CN1086586C (en) Medicine for treating cardiac and cerebral vascular diseases and its preparation
CN1241580C (en) Medicinal composition for treating hypersteogeny
CN1290551C (en) A Chinese medicinal composition for invigorating kidney and strengthening bone
CN114272329B (en) Traditional Chinese medicine composition for treating liver and kidney deficiency type cervical spondylosis, preparation and application
CN114306497B (en) Traditional Chinese medicine composition for treating kidney deficiency and blood stasis type osteoporosis, preparation and application
CN1219402A (en) Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method
CN1191751A (en) Chinese medicine Gutongning and its preparation
CN1186036C (en) Diabetes treating medicine and its prepn
CN1205989C (en) Medicine composition for treating ischemic necrosis of femur head and preparing process thereof
CN1050056C (en) Medicine for treating osteoproliferation
CN1593484A (en) Bone strengthening granule of tortoise plastron and astragalus root
CN1435217A (en) Bone-strengthening medicine and producing method thereof
CN1150015C (en) Medicine for treating leucocytopenia caused by lupus erythematosus

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee